AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and Processes
Leukodystrophy, MetachromaticLeukodystrophy, Globoid CellCerebroside-SulfataseGalactosylceramidasePsychosineHereditary Central Nervous System Demyelinating DiseasesSulfoglycosphingolipidsPelizaeus-Merzbacher DiseaseDiffuse Cerebral Sclerosis of SchilderCerebrosidesSaposinsSulfatasesSphingolipid Activator ProteinsSphingolipidosesCanavan DiseaseN-Acylsphingosine GalactosyltransferaseLeukoencephalopathiesArylsulfatasesMice, Neurologic MutantsAlexander DiseaseBrainMyelin Proteolipid ProteinRotarod Performance TestEnzyme Replacement TherapyGalactosidasesLamin Type BDemyelinating DiseasesMyelin SheathConsanguinityBrain DiseasesHeterozygote DetectionOligodendrogliaMagnetic Resonance ImagingGalactosylceramidesDisease Models, Animal

Gene therapy for leukodystrophies. (65/118)

 (+info)

Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy. (66/118)

 (+info)

Population carrier rates of pathogenic ARSA gene mutations: is metachromatic leukodystrophy underdiagnosed? (67/118)

 (+info)

Brain MRI and biological diagnosis in five Tunisians MLD patients. (68/118)

 (+info)

Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age. (69/118)

 (+info)

Toward a better understanding of brain lesions during metachromatic leukodystrophy evolution. (70/118)

 (+info)

Correction of brain oligodendrocytes by AAVrh.10 intracerebral gene therapy in metachromatic leukodystrophy mice. (71/118)

 (+info)

Diffusion and ADC-map images detect ongoing demyelination on subcortical white matter in an adult metachromatic leukodystrophy patient with autoimmune Hashimoto thyroiditis. (72/118)

 (+info)